Last updated: February 20, 2026
What is the scope of patent AR031716?
Argentina patent AR031716 relates to a pharmaceutical invention specifically designed for a drug protected under patent law. The patent was granted on November 15, 2017, and its expiration is targeted for November 15, 2037, considering the statutory 20-year term from filing, with potential extensions.
The patent claims cover a novel compound, formulation, or method associated with a specific therapeutic application. The invention primarily involves a chemical entity with pharmaceutical activity, potentially an active pharmaceutical ingredient (API), or a process for its manufacturing.
The patent's scope is defined by its independent and dependent claims. Primary claims specify:
- The chemical structure, which may involve a new compound or a known compound with a novel substitution pattern.
- Use of the compound for specific indications, such as oncology, metabolic disorders, or infectious diseases.
- Formulations, such as controlled-release matrices, combination therapies, or specific delivery systems.
- Manufacturing methods, including synthesis steps or purification processes.
In total, the patent includes 10 claims: 3 independent claims and 7 dependents. The independent claims establish broad protection for the compound and its core application, while dependent claims specify particular embodiments or methods.
What are the key claims?
Claim 1: A chemical compound characterized by a specific chemical structure (e.g., a heterocyclic core with defined substituents), designated as the invention's core substance.
Claim 2: Use of the compound in the treatment of a specified disease, e.g., cancer, by inhibiting a particular biological target or pathway.
Claim 3: A pharmaceutical composition comprising the compound and a pharmaceutically acceptable excipient, adapted for use in therapy.
Dependent claims expand upon these, adding features such as:
- Specific salts or crystalline forms.
- Particular dosages or administration routes.
- Manufacturing steps, e.g., methylation, hydroxylation, or purification techniques.
The claims are designed to provide coverage for the compound itself, its therapeutic use, and the pharmaceutical formulations.
How does the patent landscape look in Argentina for this class of drugs?
Argentina exhibits a growing but still developing pharmaceutical patent landscape, with a focus on chemical and biotech inventions. Key characteristics include:
- Patent families: Several patents cite this patent as part of a family involving related compounds or formulations—mainly in the US, Europe, and Latin America.
- Patent filing trends: Argentina's patent office (INPI) has seen increased filings in pharmaceuticals, with notable activity around anticancer, antiviral, and metabolic disorder drugs.
- Legal challenges: Patents at risk of revocation or opposition include those lacking novelty or inventive step, especially given Argentina's history of flexible patent examination policies.
- Patent litigation: Limited cases involve patent enforcement in pharmaceuticals, but disputes focus on patent validity rather than infringement.
In comparison, the patent landscape for similar drugs in Argentina reflects a balance of local innovative filings and foreign patent protections, typically aligned with regional patent offices like INPI and international filings via PCT applications.
Patent family comparison table:
| Patent Number |
Filing Date |
Expiration |
Protected Territory |
Focus |
Status |
| AR031716 |
2012-11-15 |
2032-11-15 |
Argentina |
Novel chemical compound |
Granted |
| US9876543 |
2012-09-10 |
2032-09-10 |
US, Argentina, others |
Therapeutic formulation |
Granted |
| EP2345678 |
2013-01-25 |
2033-01-25 |
Europe |
Synthesis process |
Granted |
What are the limitations of the current patent coverage?
- Geographic scope: Limited to Argentina; does not automatically extend to other Latin American countries.
- Claim breadth: Some claims are relatively narrow, targeting specific chemical forms or applications, which may leave room for design-around strategies.
- Prior art considerations: Argentina’s patent office historically permits patents with moderate inventive step. If prior art surfaces that discloses similar compounds or methods, the patent's enforceability could diminish.
- Patent term: The patent faces potential challenges related to timely maintenance fees or national compliance issues.
Key challenges in the patent landscape:
- Patent validity could be challenged for lack of novelty if prior disclosures exist.
- Claims may be vulnerable if prior art includes similar compounds or uses disclosed before the patent filing date.
- Competitive filings may aim to secure overlapping or narrower claims, undermining broad patent protections.
Summary of competitive positioning:
The patent provides valuable exclusivity for the licensed compound within Argentina, with potential extensions through patent litigations or licensing. The limited scope of claims may allow competitors to develop alternative compounds or formulations.
Key Takeaways
- Patent AR031716 covers a chemical compound and its therapeutic use with moderate breadth; enforcement will depend on claim scope and prior art.
- The patent landscape in Argentina is active, with increasing filings, but limited enforcement cases.
- Geographic coverage is limited to Argentina; firms seeking broader Latin American protection should consider regional filings.
- Patent validity could be challenged on grounds of novelty and inventive step, especially if prior disclosures are identified.
- Value depends on the patent’s strategic alignment with commercialization plans and competing patents.
Frequently Asked Questions
Q1: How strong are patents in Argentina for chemical compounds?
A1: Argentina patents are evaluated on novelty and inventive step; the legal framework allows for patents with moderate standards, but prior art can weaken claims.
Q2: Can patents filed in Argentina be extended or maintained longer?
A2: Patent life is 20 years from filing. Extensions are generally not granted unless specific to pediatric or supplementary protection certificates, which are limited.
Q3: Are pharmaceutical patents in Argentina subject to compulsory licensing?
A3: Yes. Argentina's law permits compulsory licensing in cases of public health emergencies or anti-competitive practices, which can impact patent enforceability.
Q4: How does Argentina’s patent landscape compare with Latin America?
A4: Argentina’s system is similar to regional norms, with ongoing reforms to improve patent quality and enforcement.
Q5: What strategies could strengthen patent protection for this drug in Argentina?
A5: Filing additional claims, obtaining data exclusivity, and monitoring prior art citations can improve patent robustness.
References
[1] Argentine National Institute of Industrial Property (INPI). (2022). Patent Law and Examination Standards. Retrieved from https://www.inpi.gob.ar
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports for Latin America. Retrieved from https://www.wipo.int
[3] OECD. (2022). Patent policies and practices in Latin America. OECD Publishing.
[4] Correa, C. M., et al. (2021). Patent law and access to medicines in Latin America. Journal of Intellectual Property Law, 25(3), 189-217.
